Patients with myeloproliferative neoplasms and COVID‐19 have increased rates of arterial thrombosis

Patients with myeloproliferative neoplasms and COVID‐19 have increased rates of arterial thrombosis

Abstract Background Both coronavirus disease‐2019 (COVID‐19) and myeloproliferative neoplasms (MPNs) are associated with systemic inflammation and risk of thrombosis. Risk of thrombosis in patients with COVID with and without MPNs has not been extensively studied. Methods Retrospective cohort study...

Full description

Bibliographic Details
Main Authors: Orly Leiva, Umberto Campia, Julia Snyder, Briana M. Barns, Samantha Rizzo, Candrika D. Khairani, Andrew Brunner, Hanny Al‐Samkari, Rebecca Karp Leaf, Rachel Rosovsky, Katayoon Goodarzi, Larissa Bornikova, Amir Fathi, Samuel Z. Goldhaber, Gabriela Hobbs, Gregory Piazza
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
arterial thrombosis
coronavirus
COVID‐19
myeloproliferative neoplasms
Online Access:https://doi.org/10.1002/rth2.12752

Internet

https://doi.org/10.1002/rth2.12752

Similar Items